Category: Include on Menu

Heron Therapeutics reported modest second-quarter revenue growth, but uncertainty around potential generic CINVANTI competition and a strategic alternatives process prompted the company to withdraw its full-year 2026 guidance. Key Investor Takeaways Why HRTX Stock Is in Focus Heron Therapeutics (NASDAQ:HRTX) withdrew its full-year 2026 guidance after second-quarter revenue came in below internal expectations and uncertainty…

Quanterix reported 34% second-quarter revenue growth and lower adjusted cash usage, but weaker-than-expected commercial performance prompted a substantial guidance reduction and pushed expected cash-flow break-even into 2027. Key Investor Takeaways Why QTRX Stock Is in Focus Quanterix (NASDAQ:QTRX) lowered its 2026 financial outlook after second-quarter revenue failed to meet management’s expectations despite increasing 34% year…

The pivotal study failed to show a statistically significant improvement in exercise capacity or its key secondary symptom endpoint, although prespecified subgroup and biomarker findings are prompting Tenax to pursue a revised registrational strategy with the FDA. Key Investor Takeaways Why TENX Stock Is in Focus Tenax Therapeutics (NASDAQ:TENX) reported that its 241-patient Phase 3…

The federal investment supports development of Fort Cady and precedes 5E Advanced Materials’ application for a potential $285 million project debt facility as the project moves toward a Final Investment Decision. Key Investor Takeaways Why FEAM Stock Is in Focus 5E Advanced Materials (NASDAQ:FEAM) has secured an $8 million EXIM investment for its Fort Cady…

Varex Imaging reported higher revenue, stronger non-GAAP margins and improved earnings, although tariff refunds and related customer reimbursements provided a roughly $10 million benefit to quarterly gross profit. Key Investor Takeaways Why VREX Stock Is in Focus Varex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue growth alongside substantial improvement in margins and earnings, supported by continued…

Bowman Consulting Group delivered double-digit second-quarter growth and reaffirmed its 2026 guidance, while a separate agreement to be acquired by Bernhard Capital Partners shifts investor attention toward the pending all-cash transaction. Key Investor Takeaways Why BWMN Stock Is in Focus Bowman Consulting Group (NASDAQ:BWMN) reported strong Q2 2026 revenue growth and a sharply higher backlog…

The agreement gives Socket Mobile broader access to North American mobility resellers as it targets Apple-based data capture deployments across frontline and industrial operations. Key Investor Takeaways Why SCKT Stock Is in Focus Socket Mobile (NASDAQ:SCKT) is expanding its industrial mobility distribution strategy through a new partnership with 3Eye Technologies, a value-added distributor focused on…

StrainScan Pro is being positioned for portable enterprise use across farming and post-harvest operations as Medical Care Technologies targets agricultural applications for its proprietary AI vision technology. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies (USOTC:MDCE) is expanding StrainScan Pro into agricultural quality control, positioning its proprietary AI vision software for…